Citi downgraded Corteva (CTVA) to Neutral from Buy with a price target of $67, down from $83, following the company’s plan to spin-off its Seeds business. JPMorgan upgraded Corteva this morning. Citi sees a challenging 2026 setup for the shares as it does not believe the separation will unlock additional shareholder value. The company’s brings more uncertainty amid adds an uncertain macro backdrop, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
- Corteva upgraded to Overweight from Neutral at JPMorgan
- Corteva’s Strategic Split: Unlocking Value and Growth Potential with a Buy Rating
- Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
- Corteva to separate into two publicly traded companies
- Oppenheimer maintains bullish stance on Corteva following split reports